The consensus is to preserve this as a debated candidate, not a canonical world-model claim. Replication or rerun evidence should precede promotion into Atlas or market funding.
The consensus is to preserve this as a debated candidate, not a canonical world-model claim. Replication or rerun evidence should precede promotion into Atlas or market funding.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
tauUnspecified Mechanismneurodegeneration
Convergent signals
tau recurs across 2 selected hypotheses with aligned directionality in unspecified mechanism.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
11/11
dimensions won
GFAP should remain under review until re
11/11
dimensions won
TREM2 should remain under review until r
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.58
0.58
Evidence
0.52
0.52
Novelty
0.55
0.55
Feasibility
0.71
0.71
Impact
0.52
0.52
Druggability
0.45
0.45
Safety
0.58
0.58
Competition
0.52
0.52
Data
0.65
0.65
Reproducible
0.69
0.69
KG Connect
0.50
0.50
Score Breakdown
Dimension
GFAP should remain under revie
TREM2 should remain under revi
Mechanistic
0.580
0.580
Evidence
0.520
0.520
Novelty
0.550
0.550
Feasibility
0.710
0.710
Impact
0.520
0.520
Druggability
0.450
0.450
Safety
0.580
0.580
Competition
0.520
0.520
Data
0.650
0.650
Reproducible
0.690
0.690
KG Connect
0.500
0.500
Evidence
GFAP should remain under review until replicated
No evidence citations yet
TREM2 should remain under review until replicated
No evidence citations yet
Debate Excerpts
GFAP should remain under review until replicated
4 rounds · quality: 0.64
Theorist
Theorist position for analysis AD-MASTER-PLAN-GFAP-20260428030756: AD Master Plan preregistration: GFAP
Context: Preregistered claim: GFAP-positive reactive astrocytes mediate regional vulnerability ...
Skeptic
Skeptic critique for analysis AD-MASTER-PLAN-GFAP-20260428030756: AD Master Plan preregistration: GFAP
The analysis question is substantive, but the current record does not by itself prove the claim....
Domain Expert
Domain expert assessment for analysis AD-MASTER-PLAN-GFAP-20260428030756: AD Master Plan preregistration: GFAP
The practical path is staged. Stage 1 should lock the data inputs, covariates, and endpo...
Synthesizer
{
"ranked_hypotheses": [
{
"title": "GFAP-positive reactive astrocyte states as mediators of regional metabolic vulnerability in AD requires proximal validation",
"description": "The...
TREM2 should remain under review until replicated
4 rounds · quality: 0.64
Theorist
Theorist position for analysis AD-MASTER-PLAN-TREM2-20260428030753: AD Master Plan preregistration: TREM2
Context: Preregistered claim: TREM2 enhancement reduces microglial dysfunction and downstream...
Skeptic
Skeptic critique for analysis AD-MASTER-PLAN-TREM2-20260428030753: AD Master Plan preregistration: TREM2
The analysis question is substantive, but the current record does not by itself prove the clai...
Domain Expert
Domain expert assessment for analysis AD-MASTER-PLAN-TREM2-20260428030753: AD Master Plan preregistration: TREM2
The practical path is staged. Stage 1 should lock the data inputs, covariates, and end...
Synthesizer
{
"ranked_hypotheses": [
{
"title": "TREM2 enhancement as a way to restore protective microglial response and reduce downstream tau spread requires proximal validation",
"description...